DCI Blog


Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Blood Biomarkers ID'd in Drug-Resistant Cancer Tumor Cells

While searching for a non-invasive way to detect prostate cancer cells circulating in blood, Duke Cancer Institute researchers have identified some blood markers associated with tumor resistance to two common hormone therapies. In a study published online this month in the journal Clinical Cancer...

myRESEARCHhome Offers Personalized Dashboards

myRESEARCHhome, a new web-based portal targeted at Duke researchers that puts relevant applications, resources, and information specific to researchers and their projects at their fingertips, launched late last month and continues to add useful features. Developed by Duke School of Medicine and...

Brain Tumor Center Welcomes New Administrative Director

Christina Kitchin Cone, ANP-BC, AOCNP, has been named administrative director of The Preston Robert Tisch Brain Tumor Center (PRTBTC). She assumed the new role in July. Cone was part of the PRTBTC for nearly seven years as a seasoned oncology nurse practitioner, and more recently as the Duke Cancer...

DCI's Gosselin Assumes Duke Hospital CNO Position

When she began her nursing career, Tracy Gosselin, PhD, RN, AOCN, the new chief nursing and patient care services officer for Duke University Hospital (DUH), chose right away to specialize in oncology. As a student nurse in her native Boston, she had worked with many cancer patients. Why cancer? “...

Gaskins Named Director Of Finance

Jane Gaskins, CPA, formerly general accounting manager for Duke University Health System (DUHS), has been named director of finance of Duke Cancer Institute (DCI). She assumed her new role in August. Gaskins received her Bachelor of business administration degree in accounting from Francis Marion...

Ovarian Cancer Survivors and Families Help Advance Research

It’s been called the silent killer because it spreads fairly quietly, before causing painful symptoms. By the time many women are diagnosed with ovarian cancer, its already advanced through the abdominal cavity. This is what happened to Gail Parkins, who, at the age of 54, was eventually diagnosed...

Blood Cancer Survivors and Fighters to Light the Night

Pat Luke, a volunteer with The Leukemia and Lymphoma Society, had walked in the society’s Light the Night fundraiser for 16 years — long before she became a volunteer. She began when she was the head executive administrator for the vice president of the Raleigh-based EMC Corporation, which...

Duke Musicians Play the Cancer Center Piano

The Steinway & Sons piano on the lower level of Duke Cancer Center relies on volunteers to make it sing. Sometimes, volunteers on the keys are Duke musicians – artists in residence, professors and administrators – who play for Duke Hospital patients, visitors and colleagues. When Duke Hospital...

September Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists and researchers whose work was featured in the media and academic journals this month. This list includes Francis Ali-Osman, DSc; Paul Kelly Marcom, MD; Julie Ann Sosa, MD; Terry Hyslop, PhD; and many more.

"Mystery Shopping" for Supportive Care

Using a “mystery shopper” approach, researchers at Duke Cancer Institute anonymously called most of the nation’s comprehensive cancer centers to ask whether palliative care was available, and found barriers to accurate information nearly 40 percent of the time.

Researchers ID Genes That Make Sarcomas Less Aggressive

Duke Cancer Institute and Rice University researchers have identified a network of regulatory genes (the microRNA-200 family, ZEB1, and GRHL2) they believe are driving some sarcomas toward a different cell lineage — a condition that seems to predict better patient outcomes.

Research: Variation in "Junk DNA"

All humans are 99.9 percent identical, genetically speaking. But that tiny 0.1 percent variation has big consequences, influencing the color of your eyes, the span of your hips, your risk of getting sick and in some ways even your earning potential. Although variants are scattered throughout the...